Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.016 | 0.3508 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.016 | 0.3508 | 1 |
Echinococcus granulosus | serotonin transporter | 0.016 | 0.3508 | 0.3508 |
Plasmodium vivax | kinesin-5 | 0.0053 | 0.0675 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0354 | 0.8608 | 1 |
Loa Loa (eye worm) | kinesin-like protein KLP2 | 0.0053 | 0.0675 | 0.1924 |
Entamoeba histolytica | kinesin, putative | 0.0053 | 0.0675 | 0.5 |
Loa Loa (eye worm) | serotonin transporter b | 0.016 | 0.3508 | 1 |
Echinococcus multilocularis | serotonin transporter | 0.016 | 0.3508 | 0.3508 |
Loa Loa (eye worm) | norepinephrine transporter | 0.016 | 0.3508 | 1 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.016 | 0.3508 | 0.4076 |
Schistosoma mansoni | kinesin eg-5 | 0.0053 | 0.0675 | 0.0784 |
Plasmodium falciparum | kinesin-5 | 0.0053 | 0.0675 | 1 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.016 | 0.3508 | 0.4076 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.016 | 0.3508 | 1 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.016 | 0.3508 | 0.5 |
Giardia lamblia | Kinesin-5 | 0.0053 | 0.0675 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.016 | 0.3508 | 1 |
Toxoplasma gondii | kinesin motor domain-containing protein | 0.0053 | 0.0675 | 1 |
Brugia malayi | Kinesin motor domain containing protein | 0.0053 | 0.0675 | 0.1924 |
Onchocerca volvulus | 0.016 | 0.3508 | 1 | |
Chlamydia trachomatis | Ssodium-dependent amino acid transporter | 0.0027 | 0 | 0.5 |
Echinococcus multilocularis | kinesin family 1 | 0.0406 | 1 | 1 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.016 | 0.3508 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 100 uM | PUBCHEM_BIOASSAY: Discovery of Small Molecule Probes for H1N1 Influenza NS1A. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504399] | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.